 |
市场调查报告书
商品编码
1629605
二尖瓣疾病市场：依治疗类型、适应症、依设备类型、依最终使用者、按地区Mitral Valve Disease Market, By Treatment Type, By Indication, By Device Type, By End User, By Geography |
||||||
预计2024年全球二尖瓣疾病市场规模为28亿美元，预计2031年将达51.2亿美元，2024年至2031年复合年增长率为9%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 28亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 9.00% | 2031年价值预测 | 51.2亿美元 |
二尖瓣疾病是指影响位于心臟左心房和左心室之间的二尖瓣的疾病。二尖瓣在调节从左心房到左心室的血流中扮演重要角色。二尖瓣疾病的常见类型包括二尖瓣狭窄（导致二尖瓣狭窄或阻塞）和二尖瓣瓣膜闭锁不全（导致血液通过二尖瓣逆流）。老龄化、风湿热、先天性心臟疾病、感染疾病等因素都会伤害二尖瓣并引发疾病。目前尚无治癒二尖瓣疾病的治疗方法，但治疗的目的是透过二尖瓣修復或置换术等手术来修復或更换受损的二尖瓣。
市场动态
全球二尖瓣疾病市场是由全球老年人口的成长所推动的，由于老龄化相关的心臟瓣膜退化，老年人口更容易患二尖瓣疾病。开发中国家风湿性心臟疾病盛行率的增加可能会推动预测期内的市场成长。然而，二尖瓣修復和置换手术的高成本以及缺乏熟练的医疗保健专业人员可能会阻碍市场成长。随着新的二尖瓣修復技术和技术的不断开发，市场参与者存在有利的成长机会。
本研究的主要特点
该报告对全球二尖瓣疾病市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数，对全球二尖瓣疾病市场的主要企业进行概况分析。
主要公司包括 Edwards Lifesciences Corporation、Medtronic Plc、Abbott Laboratories、Boston Scientific Corporation、Corcym UK Limited、Artivion, Inc.、ShockWave Medical, Inc.、Valcare Medical、Braile Biomedica、Labcor Laboratorios Ltda、Zydus Lifesciences Limited、Affluence Medicalence 、Tevacor製药工业有限公司、拜耳公司和诺华公司。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球二尖瓣疾病市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球二尖瓣疾病市场的各种策略矩阵，促进相关人员的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 主要进展
- 监管场景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
- 产业动态
第四章全球二尖瓣疾病市场，依治疗类型，2019-2031
- 二尖瓣修復术
- 二尖瓣置换术术
- 心臟再同步治疗（CRT）
- 二尖瓣治疗
第五章全球二尖瓣疾病市场，依适应症分类，2019-2031
- 瓣膜闭锁不全
- 二尖瓣狭窄
- 二尖瓣脱垂
第六章全球二尖瓣疾病市场，依设备类型，2019-2031
- 手术器械
- 植入装置
- 诊断设备
第 7 章 全球二尖瓣疾病市场，依最终使用者划分，2019-2031 年
- 医院
- 门诊手术中心
- 专科诊所
- 心臟復健中心
- 其他的
第八章全球二尖瓣疾病市场（按地区），2019-2031
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第9章 竞争格局
- Edwards Lifesciences Corporation
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- Corcym UK Limited
- Artivion, Inc.
- ShockWave Medical, Inc.
- Valcare Medical
- Braile Biomedica
- Labcor Laboratorios Ltda
- Zydus Lifesciences Limited
- Affluent Medical
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Novartis AG
第10章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十一章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Global mitral valve disease market is estimated to be valued at USD 2.80 Bn in 2024 and is expected to reach USD 5.12 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 2.80 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.00% | 2031 Value Projection: | US$ 5.12 Bn |
Mitral valve disease refers to conditions that affect the mitral valve located between the left atrium and left ventricle of the heart. Mitral valve plays a key role in regulating blood flow from the left atrium to the left ventricle. Some common types of mitral valve disease include mitral valve stenosis, which causes narrowing or blockage of the mitral valve, and mitral valve regurgitation or insufficiency, which allows blood to flow backward through the mitral valve. Factors such as aging, rheumatic fever, congenital heart defects, and infections can damage the mitral valve and lead to diseases. Presently, there is no cure for mitral valve disease, however, treatments aim to repair or replace the damaged mitral valve via procedures such as mitral valve repair or replacement surgeries.
Market Dynamics
Global mitral valve disease market growth is driven by rising geriatric population globally who are more prone to develop mitral valve diseases due to age-related degeneration of heart valves. Increasing prevalence of rheumatic heart disease in developing nations can drive the market growth during the forecast period. However, high costs associated with mitral valve repair and replacement surgeries along with lack of skilled healthcare professionals can hamper the market growth. Ongoing development of novel mitral valve repair technologies and techniques present lucrative growth opportunities for market players.
Key Features of the Study
This report provides in-depth analysis of the global mitral valve disease market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global mitral valve disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Corcym UK Limited, Artivion, Inc., ShockWave Medical, Inc., Valcare Medical, Braile Biomedica, Labcor Laboratorios Ltda, Zydus Lifesciences Limited, Affluent Medical, Teva Pharmaceutical Industries Ltd., Bayer AG, and Novartis AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global mitral valve disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mitral valve disease market
Market Segmentation
- Treatment Type Insights (Revenue, USD Bn, 2019 - 2031)
- Mitral Valve Repair
- Surgical Mitral Valve Repair
- Transcatheter Mitral Valve Repair
- Mitral Valve Replacement
- Mechanical Valve Replacement
- Biological Valve Replacement
- Transcatheter Aortic Valve Replacement (TAVR)
- Cardiac Resynchronization Therapy (CRT)
- Biventricular Pacing
- Implantable Cardioverter Defibrillators (ICDs)
- Mitral Valve Therapeutics
- Pharmacological Treatments
- Device-Based Therapies
- Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Mitral Valve Regurgitation
- Mitral Valve Stenosis
- Mitral Valve Prolapse
- Device Type Insights (Revenue, USD Bn, 2019 - 2031)
- Surgical Instruments
- Heart-Lung Machines
- Surgical Staplers
- Sutures
- Implant Devices
- Mitral Valve Prostheses
- Repair Devices (e.g., annuloplasty rings)
- Diagnostic Devices
- Echocardiograms
- Cardiac Imaging Systems
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Cardiac Rehabilitation Centers
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Key Players Insights
- Edwards Lifesciences Corporation
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- Corcym UK Limited
- Artivion, Inc.
- ShockWave Medical, Inc.
- Valcare Medical
- Braile Biomedica
- Labcor Laboratorios Ltda
- Zydus Lifesciences Limited
- Affluent Medical
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Novartis AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Mitral Valve Disease Market, By Treatment Type
- Global Mitral Valve Disease Market, By Indication
- Global Mitral Valve Disease Market, By Device Type
- Global Mitral Valve Disease Market, By End User
- Global Mitral Valve Disease Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Mitral Valve Disease Market, By Treatment Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Mitral Valve Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Surgical Mitral Valve Repair
- Transcatheter Mitral Valve Repair
- Mitral Valve Replacement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mechanical Valve Replacement
- Biological Valve Replacement
- Transcatheter Aortic Valve Replacement (TAVR)
- Cardiac Resynchronization Therapy (CRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biventricular Pacing
- Implantable Cardioverter Defibrillators (ICDs)
- Mitral Valve Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Pharmacological Treatments
- Device-Based Therapies
5. Global Mitral Valve Disease Market, By Indication, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Mitral Valve Regurgitation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mitral Valve Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mitral Valve Prolapse
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Mitral Valve Disease Market, By Device Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Surgical Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Heart-Lung Machines
- Surgical Staplers
- Sutures
- Implant Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mitral Valve Prostheses
- Repair Devices (e.g., annuloplasty rings)
- Diagnostic Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Echocardiograms
- Cardiac Imaging Systems
7. Global Mitral Valve Disease Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiac Rehabilitation Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Mitral Valve Disease Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Edwards Lifesciences Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Corcym UK Limited
- Artivion, Inc.
- ShockWave Medical, Inc.
- Valcare Medical
- Braile Biomedica
- Labcor Laboratorios Ltda
- Zydus Lifesciences Limited
- Affluent Medical
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Novartis AG
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
